Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study-Reference-Cited by-同舟云学术

Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study

Published:2021-12 Issue: Volume: Page:
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Palomba Maria Lia^ORCID,Cartron Guillaume,Popplewell Leslie,Ribrag Vincent,Westin Jason^ORCID,Huw Ling-Yuh,Agarwal Shefali,Shivhare Mahesh,Hong Wan-Jen^ORCID,Raval Aparna,Chang Alice C.,Penuel Elicia,Morschhauser Franck

Funder

Spectrum Pharmaceuticals

F. Hoffmann-La Roche

AstraZeneca

Genentech

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Diffuse large B cell lymphoma;Padala;StatPearls,2021

2. Soluble PD-1 but not PD-L1 levels predict poor outcome in patients with high-risk diffuse large B-cell lymphoma;Vajavaara;Cancers (Basel),2021

3. Andorsky DJ, Yamada RE, Said J, Pinkus GS, Betting DJ, Timmerman JM. Programmed death ligand 1 is expressed by non–Hodgkin lymphomas and inhibits the activity of tumor-associated T cells. Clin Cancer Res. 2011;17:4232–4244.

4. Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor;Deng;MAbs,2016

5. Current clinical applications and future perspectives of immune checkpoint inhibitors in non-Hodgkin lymphoma;Apostolidis;J Immunol Res,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic control of immunoevasion in cancer stem cells;Trends in Cancer;2024-09

2. Unraveling the Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic and Potential Therapeutic Implications;Current Issues in Molecular Biology;2024-07-05

3. Therapeutic index of targeting select chromatin complexes in human cancer patients;Current Opinion in Genetics & Development;2024-04

4. Epigallocatechin-3-gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer bothin vitroandin vivo;2024-02-21

5. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01